As part of the agreement, KannaLife will fund a new drug discovery project related to a laboratory validated phytochemical. The founding science is based on the licensed technology
The two primary endpoints of OSKIRA-1were evaluation of signs and symptoms of RA as measured by ACR20 response rates, and an X-ray endpoint referred to as modified Total
The company completed Phase I safety trial of NSI-566 stem cells in ALS and also won orphan drug designation. Upon FDA approval, a Phase II trial is scheduled
As per the agreement of Zovirax ointment, Valeant will supply Actavis with a generic version of its Zovirax ointment product and Actavis will market and distribute the product.
Three patients enrolled in the second dose level cohort completed the first treatment cycle and well tolerated the L-DOS47 therapy. Patients to be enrolled in the third cohort
The oral drug candidate APD334 is formulated to target the sphingosine 1-phosphate subtype 1 (S1P1) receptor believed to take part in the modulation of various biological responses. Arena
Livalo, developed by Kowa, is a cholesterol-lowering agent and Olmetec, developed by Daiichi, is an antihypertensive agent. Both the companies have been jointly marketing the drugs in the
The supercomputer and its supporting e-infrastructure will help over 500 life sciences and biomedical researchers, physicians and students from a consortium to gain further insights into chronic diseases
Oncomine Gene Browser will allow cancer researchers to search premier cancer genomics database for expression, copy number and mutation data while Ion Reporter Oncomine Workflow is an end-to-end
Under the partnership, Horizon will share its X-Gene Mutant and Normal (X-MAN ) cell lines with Crown who will provide animal model development, study execution and business marketing
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.